Comparison of toxicity and outcome in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapy using IMRT or VMAT.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 27914680.
- Also identified by DOI 10.1016/j.radonc.2016.11.015.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Retrospective evaluation of 188 advanced stage non-small cell lung cancer patients treated with IMRT or VMAT revealed a limited increase of moderate to severe acute esophageal toxicity after VMAT. Acute pulmonary toxicity and severe late toxicity were low. Overall survival did not differ between the IMRT and VMAT groups.
Medical subject headings
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
- Radiotherapy, Intensity-Modulated